Hemant Surgical Industries Limited has announced a strategic international collaboration by entering into a Development and Supply Agreement with GBT Korea Co., Ltd., based in the Republic of Korea. This partnership aims to leverage South Korean technological expertise to localize the production of high-end medical imaging equipment in India.
The primary goal of the agreement is the co-development and supply of C-ARM imaging devices. These devices utilize fluoroscopy X-ray technology to provide surgeons with real-time, high-resolution images during complex procedures.
Key Objectives of the Collaboration
Technological Localization: The partnership will focus on developing X-ray generators and electronic control systems locally.
Surgical Applications: The C-ARM units are designed for critical use in orthopedic, trauma, and cardiovascular surgeries, where real-time visualization is essential for precision.
Confidentiality: While the agreement is a significant milestone, the specific financial size of the contract remains undisclosed due to mutual confidentiality obligations.
Hemant Surgical confirmed that there is no shareholding involved with GBT Korea, and the transaction does not fall under related party transactions, ensuring an independent business collaboration aimed at advancing India's medical infrastructure.
Shares of Hemant Surgical Industries Limited was last trading in BSE at Rs. 269.90 as compared to the previous close of Rs. 254.65. The total number of shares traded during the day was 29200 in over 56 trades.
The stock hit an intraday high of Rs. 283.00 and intraday low of 231.10. The net turnover during the day was Rs. 7660560.00.